A PYMNTS Company

Competition Authority suspects pharmacies not stocking parallel import drugs

By  |  April 17, 2012

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The Finnish Competition Authority has voiced its suspicions that pharmacies are not stocking parallel import drugs as they are legally required to do. Parallel imports are cheaper versions of brand name drugs; they differ from generics because they are identical to Finnish drugs, but imported from cheaper EU states and repackaged. The watchdog has singled out the University Pharmacy group as the only pharmacy that complies with the law.

    Full content: YLE

     

    Related content: The EC Pharmaceutical Inquiry: Behind the Headlines, What is the Real Story on Innovation and Generic Competition in Pharmaceuticals? (Thomas Cueni, Interpharma)

     

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.